Our mission

Discover, develop, and commercialize a new class of RNA therapies informed by human genetics and disease biology to improve the lives of patients with debilitating and life-threatening diseases.

Our vision

Create transformative genetic medicines for rare and highly prevalent diseases

Meet our team

read more +

Ram Aiyar, Ph.D., MBA

Chief Executive Officer & President

read more +

Loïc Vincent, Ph.D.

Chief Scientific Officer

Todd Chappell Headshot

read more +

Todd Chappell, MBA

Chief Operating Officer

read more +

Jeffrey M. Cerio, Pharm.D., J.D.

SVP, General Counsel

read more +

Stephanie Engels

Chief People Officer

read more +

Gaozhong Zhu, Ph.D.

SVP, CMC & Technical Operations